International Patent: USE OF A PURINE COMPOUND FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER, RETT SYNDROME, AND FRAGILE X SYNDROME

GENEVA, June 19 -- MARVEL BIOTECHNOLOGY filed a patent application (CA2025/051491) for “USE OF A PURINE COMPOUND FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER, RETT SYNDROME, AND FRAGILE X SYNDROME”. With publication no. WO/2026/102521, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/522

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....